, and each is associated with discrete treatment guidelines. In the absence of definitive histologic features, this important distinction can be challenging and time-consuming, and requires confirmatory immunohistochemical stains.
Classification of lung cancer type is a key diagnostic process because the available treatment options, including conventional chemotherapy and, more recently, targeted therapies, differ for LUAD and LUSC 2 . Also, a LUAD diagnosis will prompt the search for molecular biomarkers and sensitizing mutations and thus has a great impact on treatment options 3, 4 . For example, epidermal growth factor receptor (EGFR) mutations, present in about 20% of LUAD, and anaplastic lymphoma receptor tyrosine kinase (ALK) rearrangements, present in < 5% of LUAD 5 , currently have targeted therapies approved by the Food and Drug Administration (FDA) 6, 7 . Mutations in other genes, such as KRAS and tumor protein P53 (TP53) are very common (about 25% and 50%, respectively) but have proven to be particularly challenging drug targets so far 5, 8 . Lung biopsies are typically used to diagnose lung cancer type and stage. Virtual microscopy of stained images of tissues is typically acquired at magnifications of 20 × to 40 × , generating very large two-dimensional images (10,000 to > 100,000 pixels in each dimension) that are oftentimes challenging to visually inspect in an exhaustive manner. Furthermore, accurate interpretation can be difficult, and the distinction between LUAD and LUSC is not always clear, particularly in poorly differentiated tumors; in this case, ancillary studies are recommended for accurate classification 9, 10 . To assist experts, automatic analysis of lung cancer whole-slide images has been recently studied to predict survival outcomes 11 and classification 12 . For the latter, Yu et al. 12 combined conventional thresholding and image processing techniques with machine-learning methods, such as random forest classifiers, support vector machines (SVM) or Naive Bayes classifiers, achieving an AUC of ~0.85 in distinguishing normal from tumor slides, and ~0.75 in distinguishing LUAD from LUSC slides. More recently, deep learning was used for the classification of breast, bladder and lung tumors, achieving an AUC of 0.83 in classification of lung tumor types on tumor slides from The Cancer Genome Atlas (TCGA) 13 . Analysis of plasma DNA values was also shown to be a good predictor of the presence of non-small cell cancer, with an AUC of ~0.94 (ref. 14 ) in distinguishing LUAD from LUSC, whereas the use of immunochemical markers yields an AUC of ~0.941 15 .
Here, we demonstrate how the field can further benefit from deep learning by presenting a strategy based on convolutional neural networks (CNNs) that not only outperforms methods in previously , renal tissue segmentation 21 and glomeruli localization 22 , breast cancer diagnosis 23, 24 , colon tumor analysis 25 , glioma grading in brain tumors 26 , epithelial tissue identification in prostate cancer 27 and osteosarcoma diagnosis 28 . CNNs have also been studied with regard to classification of lung patterns on computerized tomography (CT) scans, achieving an f-score of ~85.5% (ref. 29 ). To study the automatic classification of lung cancer whole-slide images, we used the inception v3 architecture 30 and whole-slide images of hematoxylin and eosin (H&E)-stained lung tissue from TCGA obtained by surgical excision followed by frozen section preparation. In 2014, Google won the ImageNet Large-Scale Visual Recognition Challenge by developing the GoogleNet architecture 31 , which increased the robustness to translation and nonlinear learning abilities by using microarchitecture units called inception. Each inception unit includes several nonlinear convolution modules at various resolutions. Inception architecture is particularly useful for processing the data in multiple resolutions, a feature that makes this architecture suitable for pathology tasks. This network has already been successfully adapted to other specific types of classifications like skin cancers 32 and diabetic retinopathy detection 33 .
Results
A deep-learning framework for the automatic analysis of histopathology images. The purpose of this study was to develop a deep-learning model for the automatic analysis of tumor slides using publicly available whole-slide images available in TCGA 34 and to subsequently test our models on independent cohorts collected at our institution. The TCGA dataset characteristics and our overall computational strategy are summarized in Fig. 1 (Methods) . We used 1,634 whole-slide images from the Genomic Data Commons database: 1,176 tumor tissues and 459 normal tissues (Fig. 1a) . The 1,634 whole-slide images were split into three sets: training, validation and testing (Fig. 1b) . Importantly, this ensures that our model is never trained and tested on tiles (see below) obtained from the same tumor sample. Because the sizes of the whole-slide images are too large to be used as direct input to a neural network (Fig. 1c) , the network was instead trained, validated and tested using 512 × 512 pixel tiles, obtained from nonoverlapping 'patches' of the wholeslide images. This resulted in tens to thousands of tiles per slide, depending on the original size (Fig. 1d) .
Based on the computational strategy outlined in Fig. 1 , we present two main results. First, we develop classification models that classify whole-slide images into normal lung, LUAD or LUSC with an accuracy that is significantly higher than previous work (AUC of 0.97 compared to 0.75 (ref.
12
) and 0.83 (ref. 13 )) and comparable to results from pathologists. Unlike previous work 12, 13 , the performance of our classification models was tested on several independent datasets: biopsies and surgical resection specimens either prepared as frozen sections or as FFPE tissue sections. Second, starting with the LUAD regions as predicted by the LUAD versus LUSC versus normal classification model, we utilize the same computational pipeline ( Fig. 1) to train a new model in order to predict the mutational status of frequently mutated genes in lung adenocarcinoma using whole-slide images as the only input. The entire workflow of our computational analysis is summarized in Supplementary Fig. 1 .
Deep-learning models generate accurate diagnosis of lung histopathology images. Using the computational pipeline of Fig. 1 , we first trained inception v3 to recognize tumor versus normal. To assess the accuracy on the test set, the per-tile classification results were aggregated on a per-slide basis either by averaging the probabilities obtained on each tile or by counting the percentage of tiles positively classified, thus generating a per-slide classification (Methods). The former approach yielded an AUC of 0.990, and the latter yielded 0.993 ( Supplementary Fig. 2a and Supplementary  Table 1) for normal-versus-tumor classification, outperforming the AUC of ~0.85 achieved by the feature-based approach of Yu et al. 12 , of ~0.94 achieved by plasma DNA analysis 14 and comparable or better than molecular profiling data (Supplementary Table 2 ).
Next, we tested the performance of our approach on the more challenging task of distinguishing LUAD and LUSC. To do this, we first tested whether convolutional neural networks can outperform the published feature-based approach, even when plain transfer learning is used. For this purpose, the values of the last layer of inception v3-previously trained on the ImageNet dataset to identify 1,000 different classes-were initialized randomly and then trained for our classification task. After aggregating the statistics on a per-slide basis ( Supplementary Fig. 2b ), this process resulted in an AUC of 0.847 (Supplementary Table 1 ); i.e., a gain of ~0.1 in AUC compared to the best results obtained by Yu et al. 12 using image features combined with random forest classifier. The performance can be further improved by fully training inception v3, leading to an AUC of 0.950 when the aggregation is done by averaging the pertile probabilities ( Supplementary Fig. 2c ). These AUC values are improved by another 0.002 when the tiles previously classified as 'normal' by the first classifier are not included in the aggregation process (Supplementary Table 1) .
We further evaluated the performance of the deep-learning model by training and testing the network on a direct three-way classification into the three types of images (normal, LUAD, LUSC). Such an approach resulted in the highest performance with all the AUCs improved to at least 0.968 ( Supplementary Fig.  2d and Supplementary Table 1 ). In addition to working with tiles at 20 × magnification, we investigated the impact of the magnification and field of view of the tiles on the performance of our models. As low-resolution features (nests of cells, circular patterns) may also be useful for classification of lung cancer type, we used slides showing a larger field of view to train the model by creating 512-× 512-pixel tiles of images at 5 × magnification. The binary and three-way networks trained on such slides led to similar results ( Supplementary Fig. 2e ,f and Supplementary Table 1 ). Supplementary Fig. 2g ,h and Supplementary Table 2 summarize and compare the performance of the different approaches explored in this study and in previous work.
Comparison of deep-learning model to pathologists. We then asked three pathologists (two thoracic pathologists and one anatomic pathologist) to independently classify the whole-slide H&E images in the test set by visual inspection alone, independently of the classification provided by TCGA. Overall, the performance of our models was comparable to that of each pathologist ( Supplementary  Fig. 2b-f, pink cross) . Supplementary Fig. 2i shows that 152 slides in our test set have a true positive probability above 0.5 (according to our model), and for 18 slides, this probability is below 0.5. Of the slides that were incorrectly classified by our model, 50% were also misclassified by at least one of the pathologists, whereas 83% of those incorrectly classified by at least one of the pathologists (45 out of 54) were correctly classified by the algorithm. We then measured the agreement between the TCGA classification and that of each pathologist, of their consensus and finally of our deep-learning model (with an optimal threshold leading to sensitivity and specificity of 89% and 93%) using Cohen's Kappa statistic (Supplementary Table 3 ). We observed that the agreement of the deep-learning model with TCGA was slightly higher (0.82 versus 0.67 for pathologist 1, 0.70 for pathologist 2, 0.70 for pathologist 3, and 0.78 for the consensus) but did not reach statistical significance (P values of 0.035, 0.091, 0.090 and 0.549, respectively, estimated by a two-sample two-tailed z-test score). Regarding time effort, it can take a pathologist one to several minutes to analyze a slide depending on the difficulty of distinguishing each case.
Furthermore, in the absence of definitive histologic features, confirmatory immunohistochemical stains are required and can delay diagnosis for up to 24 h. The processing time of a slide by our algorithm depends on its size; currently, it takes ~20 s to calculate per-tile classification probabilities on 500 tiles (the median number of tiles per slide is < 500) on a single Tesla K20m GPU. Considering the possibility of using multiple GPUs to process tiles in parallel, classification using our model can be executed in a few seconds. The scanning time of each slide using the Aperio scanner (Leica) is currently 2-2.5 min for a slide at 20 × , but with the 2017 FDA approval of the new ultra-fast digital pathology scanner from Philipps 35 , this step will probably no longer be bottleneck in the near future.
Testing on independent cohorts demonstrates generalizability of the neural network model. The model was then evaluated on independent datasets of lung cancer whole-slide images taken from frozen sections (98 slides) and FFPE sections (140 slides) as well as lung biopsies (102 slides) obtained at the New York University (NYU) Langone Medical Center (Fig. 2a-c) . In this case, the pathologists' diagnosis, based on morphology and supplemented by immunohistochemical stains (TTF-1 and p40 for LUAD and LUSC respectively) when necessary, was used as the gold standard (i.e., used as a ground truth to assess the performance of our approach). Each TCGA image is almost exclusively composed of either LUAD cells, LUSC cells, or normal lung tissue. As a result, several images in the two new datasets contain features that the network has not been trained to recognize, making the classification task more challenging. We observed that features, including blood clot, blood vessels, inflammation, necrotic regions, and regions of collapsed lung are sometimes labeled as LUAD, bronchial cartilage is sometimes labeled as LUSC, and fibrotic scars can be misclassified as normal or LUAD.
As demonstrated in Supplementary Fig. 3a , TCGA images have significantly higher tumor content compared to the independent datasets, and tumor content correlates with the ability of the algorithm to generalize on these new unseen samples. To reduce the bias generated by some of these particular features that are found outside the tumor areas and only test the ability of our network to dissociate LUAD, LUSC and normal tissues regions, the AUCs in Fig. 2 were computed on regions of high tumor content that were manually selected by a pathologist. Considering that new types of artifacts were also observed on some older slides (dull staining, uneven staining, air bubbles under the slide cover leading to possible distortion), the results obtained on these independent cohorts are very encouraging. At 20 × magnification, more tiles are fully covered by some of these 'unknown' features, whereas at 5 × magnification, the field of view is larger and contains features known by the classified (tumor or normal cells) in many more tiles, allowing a more accurate per-tile classification. This, in turn, leads to a more accurate per-slide classification.
Taken together, these observations may explain why the AUC of the classifier on 5 × -magnified tiles is mostly higher than the one from 20 × -magnified tiles. Interestingly, even though the slides from FFPE and biopsy sections were preserved using a different technique from those in the TCGA database, the performance remains satisfactory (Fig. 2b) . For the biopsies, we noticed that poor performance was not only associated with regions where ). In one-third of the cases collected, the original diagnosing pathologist was not able to visually determine the tumor type; TTF-1 and p40 stains were therefore used to identify LUAD and LUSC cases, respectively. Notably, when splitting the dataset, we noticed that our model is able to classify those difficult cases as well: at 20 × , the LUAD and LUSC AUCs for those difficult cases were 0.809 (confidence interval (CI), 0.639-0.940) and 0.822 (CI, 0.658-0.951), respectively, which is only slightly lower than the slides considered obvious for the pathologists (for LUAD, AUC of 0.869 (CI, 0.753-0.961) and for LUSC, 0.883 (CI, 0.777-0.962)).
Finally, we tested whether it is possible to replace the manual tumor selection process by an automatic computational selection. To this end, we trained inception v3 to recognize tumor areas using the pathologist's manual selections. Training and validation were done on two out of the three datasets, and testing was performed on the third one. For example, to test the performance of the tumorselection model on the biopsies, we trained the model to recognize the tumor area on the frozen and FFPE samples, then applied this model to the biopsies and finally applied the TCGA-trained threeway classifier on the tumor area selected by the automatic tumor selection model. The per-tile AUC of the automatic tumor selection model (using the pathologist's tumor selection as reference) was 0.886 (CI, 0.880-0.891) for the biopsies, 0.797 (CI, 0.795-0.800) for the frozen samples, and 0.852 (CI, 0.808-0.895) for the FFPE samples. As demonstrated in Supplementary Fig. 3a (right-most bar of each graph), we observed that the automatic selection resulted in a performance that was comparable to the manual selection (slightly better AUC in frozen, no difference in FFPE, and slightly worse in biopsies; see also Supplementary Fig. 3b ).
Predicting gene mutational status from whole-slide images. We next focused on the LUAD slides and tested whether CNNs can be trained to predict gene mutations using images as the only input. For this purpose, gene mutation data for matched patient samples were downloaded from TCGA. To make sure the training and test sets contained enough images from the mutated genes, we only selected those which were mutated in at least 10% of the available tumors. From each LUAD slide, only tiles classified as LUAD by our classification model were used for this task in order to avoid biasing the network to learn LUAD-specific versus LUSC-specific mutations and to focus instead on distinguishing mutations relying exclusively on LUAD tiles. Inception v3 was modified to allow 
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multioutput classification (Methods): training and validation was conducted on ~212,000 tiles from ~320 slides, and testing was performed on ~44,000 tiles from 62 slides. Box plot and ROC curve analysis (Fig. 3a,b and Supplementary Fig. 5 ) show that six frequently mutated genes seem predictable using our deep-learning approach; AUC values for serine/threonine protein kinase 11 (STK11), EGFR, FAT atypical cadherin 1 (FAT1), SET binding protein 1 (SETBP1), KRAS and TP53 were between 0.733 and 0.856 (Table 1) . Availability of more data for training is expected to substantially improve the performance. As mentioned earlier, EGFR already has targeted therapies. STK11, also known as liver kinase 1 (LKB1), is a tumor suppressor inactivated in 15-30% of non-small cell lung cancers 36 and is also a potential therapeutic target: it has been reported that phenformin, a mitochondrial inhibitor, increases survival in mice 37 . Also, it has been shown that STK11 mutations in combination with KRAS mutations resulted in more aggressive tumors 38 . FAT1 is an ortholog of the Drosophila fat gene involved in many types of cancers, and its inactivation is suspected to increase cancer cell growth 39 . Mutation of the tumor suppressor gene TP53 is thought to lead to resistance to chemotherapy, resulting in lower survival rates in small-cell lung cancers 40 . Mutation in SETBP1, like KEAP1 and STK11, has been identified as one of the signatures of LUAD 41 . Finally, for each gene, we compared the classification achieved by our deep-learning model with the allele frequency (Fig. 3c) . Among the gene mutations predicted with a high AUC, in four of them, classification probabilities (as reported by our model) were associated with allele frequency: FAT1, KRAS, SETBP1, and STK11, demonstrating that these probabilities may reflect the percentage of cells promising results for at least six genes. a, Distribution of probability of mutation in genes from slides where each mutation is present or absent (tile aggregation by averaging output probability). b, ROC curves associated with the top four predictions in a. c, Allele frequency as a function of slides classified by the deep-learning network as having a certain gene mutation (P ≥ 0.5) or the wild type (P < 0.5). P values were estimated with the two-tailed Mann-Whitney U-test and are shown as nonsignificant (n.s.; P > 0.05), *P ≤ 0.05, **P ≤ 0.01 or ***P ≤ 0.001. For a, b and c, n = 62 slides from 59 patients. For the two box plots, whiskers represent the minima and maxima. The middle line within the box represents the median. 
effectively affected by the mutation. Looking, for example, at the predictions performed on the whole-slide image from Fig. 4a , our process successfully identified TP53 (allele frequency of 0.33) and STK11 (allele frequency of 0.25) as the two genes that were most likely mutated (Fig. 4a) . The heatmap shows that almost all of the LUAD tiles are highly predicted to show TP53-mutant-like features (Fig. 4b) , and two major regions with STK11-mutant-like features (Fig. 4c) . Interestingly, when the classification is applied on all tiles, it shows that even tiles classified as LUSC present TP53 mutations (Fig. 4d) , whereas the STK11 mutant is confined to the LUAD tiles (Fig. 4e) . These results are realistic considering that, as mentioned earlier, STK11 mutation is a signature of LUAD 41 , whereas TP53 mutation is more common in all human cancers.
Future work on deep-leaning model visualization tools 42 would help identify and characterize the features used by the neural network. To visualize how the mutations and tiles are organized in the multidimensional space of the network, we used as before a t-SNE representation 43 with the values of the last fully connected layer used an inputs. On the resulting plots ( Supplementary Fig. 6a) , each dot represents a tile, and its color is proportional to the probability of the gene to be mutated, as estimated by our model. The tileembedded representation (Supplementary Fig. 6b ) allows the visual comparison of tiles sharing similar predicted mutations. Clusters of specific mutations can be seen at the surroundings of the plot. The top left group, for example, shows tiles in which the aggressive double mutants KRAS and STK11 are both present, while the small one at the top shows tiles with KEAP1 and SETBP1 mutants and the cluster on the top right has been associated with the triple mutation of FAT1, LRP1B, and TP53. Future analysis with laser-capture microdissection could provide some additional spatial information and could study the limits and precision of such a method 44 . Although our current analysis does not define the specific features used by the network to identify mutations, our results suggest that such genotype-phenotype correlations are detectable. Determining mutation status from a histological image and bypassing additional testing is important in lung cancer in particular, as these mutations often carry prognostic as well as predictive information. Previous work has shown associations between clinically important mutations and specific patterns of lung adenocarcinoma 45, 46 as well as with the histologic changes that correspond with the evolution of resistance 47 . More recently, Chiang et al. 48 empirically demonstrated the relationship between a defining mutation and the unique morphology of a breast cancer subtype. Some of the mutations with high AUCs highlighted in our study (like those in STK11, TP53 and EGFR) have been shown to affect cell polarity and cell shape [49] [50] [51] , two features that are not routinely assessed during the pathologic diagnosis. We note that our model was not able to detect ALK mutations, although such tumors have been associated with specific histologic features, such as a solid pattern with signet ring cells or a mucinous cribriform pattern 52, 53 . Although the prevalence of ALK mutations is very low (reportedly ranging from 1.8-6.4% (ref. 54 )), their presence is routinely determined via immunohistochemistry, as tumors with this mutation may respond to ALK inhibitors 6, 7 . To confirm that our models can be applied to independent cohorts, we tested the prediction of the EGFR mutant using 63 whole-slide images of lung resection specimens with known EGFR mutational status: 29 EGFR mutant and 34 EGFR wild-type samples. This independent dataset has some important differences from the TCGA dataset, which may negatively impact the evaluation of the TCGA-based model: (i) the samples were not frozen but were instead preserved using FFPE, and (ii) only 22 samples had sequencing data to support the EGFR mutational status with high specificity and sensitivity; the rest of the samples (i.e., 65% of the test set) have been analyzed by immunohistochemical (IHC) stains 55 , a technique known for its high specificity but low sensitivity 56, 57 and which solely identifies the two most common mutations 55 (p.L858R and p.E746_A750del). On the other hand, data from the TCGA dataset used for training were identified with the next-generation sequencing (NGS) tools Illumina HiSeq 2000 or Genome Analyzer II. Our TCGA model has therefore been trained to detect not only p.L858R and p.E746_A75-del, but many other EGFR mutants and deletions, such as p.G719A, p.L861Q or p.E709_T710delinsD, for example.
Despite these caveats, we believed that it would still be important to demonstrate that our TCGA-derived models can at least perform significantly better than random in the independent NYU cohort. Indeed, the results showed an AUC of 0.687 (CI, 0.554-0.811), with a higher AUC (0.750; CI, 0.500-0.966) in samples validated by sequencing than in those tested by IHC (AUC, 0.659; CI, 0.485-0.826). Although the sequencing-based AUC of 0.75 is lower than the one estimated on the TCGA test set (0.83), we believe that most of this difference can be attributed to the difference in the sample preparation (frozen versus FFPE). We noticed that the discrepancy (~0.08) is similar to the difference observed in the AUCs of LUAD from the TCGA dataset (0.97) and the FFPE dataset (0.83). In the classification task, this issue was solved by lowering the magnification to 5 × . However, this is not useful for the mutation prediction task, because it appears that 20 × is necessary to capture predictive image features (the TCGA EGFR mutation prediction model at 5 × has a random 
performance). Still, we believe that the 0.75 AUC we obtained on the sequencing-validated subset of EGFR-mutant cases demonstrates that the model can generalize on independent datasets.
Discussion
Our study demonstrates that convolutional neural networks, such as Google's inception v3, can be used to assist in the diagnosis of lung cancer from histopathology slides: it almost unambiguously classifies normal versus tumor tissues (~0.99 AUC) and distinguishes lung cancer types with high accuracy (0.97 AUC), reaching sensitivity and specificity comparable to that of a pathologist. Interestingly, around half of the TCGA whole-slide images misclassified by the algorithms have also been misclassified by the pathologists, highlighting the intrinsic difficulty in distinguishing LUAD from LUSC in some cases. However, 45 out of 54 of the TCGA images misclassified by at least one of the pathologists were assigned to the correct cancer type by the algorithm, suggesting that our model could be beneficial in assisting the pathologists in their diagnosis. The confusions matrices in Supplementary Table 4 detail the discrepancies between the different classifications, and Supplementary Fig.  7 shows a few examples in which our model correctly classified whole-slide images misclassified by at least one of the pathologists. These images show poorly differentiated tumors that lack the classic histological features of either type (keratinization for LUSC and gland formation/recognizable histological pattern for LUAD). The high accuracy of our model was achieved despite the presence of various artifacts in the TCGA images that were related to sample preparation and preservation procedures. However, the TCGA images used to train the deep neural network may not fully represent the diversity and heterogeneity of tissues that pathologists typically inspect, which may include additional features such as necrosis, blood vessels, and inflammation. More slides containing such features would be needed to retrain the network in order to further improve its performance. Despite this and the fact that the process was trained on frozen images, tests show very promising results on tumor classification from FFPE sections as well. Although it has been suggested that mutations could be predicted from H&E images (AUC of ~0.71 for the prediction of SPOP mutations from prostate cancer H&E images 58 ), before this study, it was unclear whether gene mutations would affect the pattern of tumor cells on a lung cancer whole-slide image, but training the network using the presence or absence of mutated genes as a label revealed that there are certain genes whose mutational status can be predicted from image data alone: EGFR, STK11, FAT1, SETBP1, KRAS, and TP53. Notably, the presence of STK11 mutations can be predicted with the highest accuracy (~0.85 AUC). A limiting factor in obtaining higher accuracies lies in the small number of slides that contain positive instances (i.e., the gene mutations) available for training; therefore, our models can greatly benefit from larger datasets that may become available in the near future. The ability to quickly and inexpensively predict both the type of cancer and the gene mutations from histopathology images could be beneficial to the treatment of patients with cancer given the importance and impact of these mutations 6, [36] [37] [38] [39] [40] [41] . Overall, this study demonstrates that deep-learning convolutional neural networks could be a very useful tool for assisting pathologists in their classification of whole-slide images of lung tissues. This information can be crucial in applying the appropriate and tailored targeted therapy to patients with lung cancer, increasing thereby the scope and performance of precision medicine that aims at developing a multiplex approach with patient-tailored therapies 59 . The diagnosis and therapy differ considerably between LUSC and LUAD and may depend on the mutational status of specific genes. In particular, when inspecting frozen section biopsies, pathologists only rely on morphology and may need immunostaining for the most difficult cases; our algorithm, which still achieves an AUC above 0.8 on biopsies that usually require immunostaining, can be used as an adjunct to telepathology to speed up diagnosis and classification during intraoperative consultation. As a result of advances in our understanding of lung cancer and a concomitant rise in the number and types of treatment options, the role of the pathologist in the diagnosis and management of this disease is substantially more complex than cancer type distinction and even determination of mutational status. Although our computational analyses may play a role in the initial diagnosis with the benefit of providing important prognostic information based on an H&E image alone, the pathologist has additional tasks, such as staging the tumor and, in an increasing number of cases, estimating response to treatment.
In the future, we would ideally extend the classification to other types of less common lung cancers (large-cell carcinoma, small-cell lung cancer) and histological subtypes of LUAD (acinar, lepidic, papillary, micropapillary, and solid) as well as to non-neoplastic features including necrosis, fibrosis, and other reactive changes in the tumor microenvironment, though the amount of data currently available is insufficient. We hope that by extending our algorithm to recognize a wider range of histologic features, followed by providing a quantitative and spatial assessment as in our heatmaps, we will be able to aid aspects of the pathologists' evaluation that are well-suited to automated analyses. We hope that this computational approach could play a role in both routine tasks and difficult cases (for example, distinguishing intrapulmonary metastases from multiple synchronous primary lung cancers) in order to allow the pathologist to concentrate on higher-level decisions, such as integrating histologic, molecular, and clinical information in order to guide treatment decisions for individual patients. 
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Methods TCGA lung cancer whole-slide image dataset. Our dataset comes from the NCI Genomic Data Commons 34 , which provides the research community with an online platform for uploading, searching, viewing and downloading cancerrelated data. All freely available slide images of Lung cancer were uploaded from this source. We studied the automatic classification of 'solid tissue normal' and 'primary tumor' slides using a set of 459 and 1,175, respectively, H&E-stained histopathology whole-slide images 60, 61 . Then, the 'primary tumor' images were classified between LUAD and LUSC types using a set of 567 and 608, respectively, of those whole-slide images. The labels provided by the TCGA database were used as our gold standard. Those labels were the result of a consensus as explained by the GDC data curator (personal communication): first, the submitting institutions were asked to review each sample prior sending it to confirm the diagnosis. Then, a slide from the sample was reviewed by a TCGA contracted expert thoracic pathologist. In the event of a disagreement, the slide would be reviewed by one or more other expert thoracic pathologists. Out of the 170 slide images in our test set, only 1 image was tagged as leading to inconsistent labels (and about 30 images had no information about it).
Image preprocessing generating 987,931 tiles. The slides were tiled in nonoverlapping 512 × 512 pixel windows at a magnification of 20 × using the openslide library67 (533 of the 2,167 slides initially uploaded were removed because of compatibility and readability issues at this stage). The slides with a low amount of information were removed; i.e., all the tiles where > 50% of the surface was covered by background (for which all the values are below 220 in the RGB color space). This process generated nearly 1,000,000 tiles. For information regarding the number of tiles and slides as well as LUAD and LUSC classification, see Supplementary Tables 5 and 6 .
Deep learning with convolutional neural networks. We used 70% of those tiles for training, 15% for validation, and 15% for final testing (Supplementary Tables 5  and 6 ). The tiles associated with a given slide were not separated but associated as a whole to one of these sets to prevent overlaps between the three sets. Typical convolutional neural networks (CNNs) consist of several levels of convolution filters, pooling layers and fully connected layers. We based our model on inception v3 architecture36. This architecture makes use of inception modules which are made of a variety of convolutions having different kernel sizes and a max pooling layer. The initial 5 convolution nodes are combined with 2 max pooling operations and followed by 11 stacks of inception modules. The architecture ends with a fully connected and then a softmax output layer. For normal versus tumor tile classification, we fully trained the entire network. For the classification of type of cancer, we followed and compared different approaches to achieve the classification: transfer learning, which includes training only the last fully connected layer, and training the whole network. Tests were implemented using the Tensorflow library (http://tensorflow.org).
Transfer learning on inception v3. We initialized our network parameters to the best parameter set that was achieved on ImageNet competition. We then fine-tuned the parameters of the last layer of the network on our data via back propagation. The loss function was defined as the cross entropy between predicted probability and the true class labels, and we used RMSProp69 optimization, with learning rate of 0.1, weight decay of 0.9, momentum of 0.9, and epsilon of 1.0 method for training the weights. This strategy was tested for the binary classification of LUAD versus LUSC.
Training the entire inception v3 network. The inception v3 architecture was fully trained using our training datasets, following the procedure previously described 30 . Similar to transfer learning, we used back-propagation, cross entropy loss, and the RMSProp optimization method as well as the same hyperparameters as the transfer-learning case for the training. In this approach, instead of only optimizing the weights of the fully connected layer, we also optimized the parameters of previous layers, including all of the convolution filters of all layers. This strategy was tested on three classifications: normal versus tumor, LUAD versus LUSC and normal versus LUAD versus LUSC. The training jobs were run for 500,000 iterations. We computed the cross-entropy loss function on the train and validation datasets, and we used the model with best validation score as our final model. We did not tune the number of layers or hyperparameters of the inception network, such as size of filters. As this training gave the best results, we also investigated the importance of training the network on a larger field of view at the expense of a lower resolution. Whole-slide images were tiled at a magnification of 5× (keeping the tile size at 512 × 512 pixels) and the network was again fully trained.
Identification of gene mutations.
To study the prediction of gene mutations from histopathology images, we modified the inception v3 to perform multitask classification rather than a single-task classification. Each mutation classification was treated as a binary classification, and our formulation allowed multiple mutations to be assigned to a single tile. We optimized the average of the cross entropy of each individual classifier. To implement this method, we replaced the final softmax layer of the network with a sigmoid layer, to allow each sample to be associated with several binary labels 62 . We used the RMSProp algorithm for the optimization, and fully trained this network for 500,000 iterations using only LUAD whole-slide images, each one associated with a 10-cell vector, and each cell associated to a mutation and set to 1 or 0 depending on the presence or absence of the mutation. Only the most commonly mutated genes were used (Supplementary Table 7 ), leading to a training set of 223,185 tiles. Training and validation were done over 500,000 iterations ( Supplementary Fig. 8) . The test was then achieved on the tiles, and aggregation on the n = 62 test slides for which at least one of these mutations is present was done only if the tile was previously classified as 'LUAD' by the normal, LUAD and LUSC three-classes classifier.
Statistical analysis. Once the training phase was finished, the performance was evaluated using the testing dataset, which is composed of tiles from slides not used during the training. We then aggregated the probabilities for each slide using two methods: either average of the probabilities of the corresponding tiles, or percentage of tiles positively classified. For the binary LUAD and CLUSC classifiers, n = 170 slides from 137 patients; and for the normal and tumor and for the three-way classifiers, n = 244 slides from 137 patients. The ROC curves and the corresponding AUC were computed in each case 63 using the python library sklearn 64 . CIs at 95% were estimated by 1,000 iterations of the bootstrap method 65 . Tumor slides could contain a certain amount of normal tiles. Therefore, we also checked how the ROC and AUC were affected when tiles classified as normal were removed from the aggregation. We asked three pathologists to manually label the TCGA test LUAD and LUSC images and compared the agreements between the ratings using the Cohen's Kappa statistic 66, 67 , comparing it to the binary LUAD and LUSC deep-learning classifier using the optimal threshold of 0.4 and 0.6 (optimal threshold is here defined as the point of the ROC curve which is closest to the perfect (1,0) coordinate). Heatmaps were also generated for some tested slides to visualize the differences between the two approaches and to identify the regions associated with a certain cancer type. To analyze more thoroughly the network trained on gene mutations, we used the Barnes-Hit implementation of the t-SNE technique 43 to reduce the dimensionality and facilitate the visualization of the classes. The values associated with the last fully connected layer were used as an input, and theta was set to 0.5, perplexity to 50, and 10,000 iterations. For the LUAD and LUSC classifier, the t-SNE plot was generated using n = 149,790 tiles of 244 slides from 137 patients. For the gene mutation prediction task, the t-SNE plot was generated using n = 24,144 tiles of 62 slides from 59 patients. Mutation probability distributions and relationship to allele frequency were analyzed with the two-tailed Mann-Whitney U-tests and computed using the same dataset (62 slides from 59 patients).
Visualization of features identified by the three-way classifier in highconfidence tiles. In Supplementary Fig. 9 , we present examples of LUSC and LUAD slides, together with heatmaps generated by our algorithm, in which the color of each tile corresponds to the class assigned by our algorithm (LUAD, LUSC or normal), and the color shade is proportional to the classification probability. The LUSC image shows most of its tiles with a strong true positive probability for LUSC classification, while in the LUAD image, the largest regions indeed have strong LUAD features, with normal cells on the side (as confirmed by our pathologist), and some light blue tiles indicating the existence of LUSC-like features in this tumor. In Supplementary Fig. 10 , the values of the last fully connected layer are visualized using a t-SNE representation, which generates 2-D scatterplots of highdimensional features 43 . For tiles associated with LUSC, we note a predominance of areas of keratinization and dyskeratotic cells as well as rare foci of cells with prominent intracellular bridging. Among the tiles denoted LUAD, the predominant feature noted is the presence of distinct gland forming histological patterns, such as lepidic and acinar (well differentiated) and micropapillary (poorly differentiated). These include well-differentiated patterns (lepidic and acinar) as well as poorly differentiated types (micropapillary). At the center of the t-SNE, regions that cannot be clearly associated with either LUAD or LUSC are composed of tiles with conspicuous preservation artifact, minute foci of tumor, or areas of interstitial/ septal fibrosis. Then, the area designated as normal is composed of tiles showing benign lung parenchyma, focal fibrosis or inflammation, as well as rare LUAD with preservation artifacts. Interestingly, the area with tiles which could not be designated normal, LUAD or LUSC with high confidence, shows both benign and malignant lung tissue in a background of dense fibrosis and/or inflammation.
Tests on independent cohorts. To challenge the trained algorithm and identify its limitations, we tested the three-way classifier with different cohorts. Images of lung cancers were obtained from the New York University Langone Medical Center from both frozen (75 of LUAD and 23 of LUSC), FFPE sections (74 LUAD, 66 LUSC) and biopsies (51 LUAD and 51 LUSC). The diagnosis used as true positive for these cases are based on morphology (gland formation for adenocarcinoma and keratinization and intracellular bridges for squamous cells), with the cases classified according to the World Health Organization; for the more challenging cases, immunostaining was performed. Because biopsies can be much narrower, during the tiling process at 5 × magnification, a tile was kept if at least 20% was covered by the tissue instead of 50%. As those external slides also contained a lot of elements the Data analysis code is also available on https://github.com/ncoudray/DeepPATH (ROC curve, heatmap) and has also used python language and libraries as well as inception v3 architecture coded with tensorflow 1.0 (https://github.com/tensorflow/).
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No statistical methods were used to predetermine sample size. Sample size was determined by the number of cases available in the databases mined. The TCGA database images are composed of more than 1,500 slides leading to hundreds of thousands of tiles for training. For the independent cohorts, we increased the number of slides to around 100 for each of them (98 frozen sections, 140 FFPE and 102 biopsies) as requested by the reviewers.
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The results were further tested using independent cohorts. Training, validation and testing was done once for each task with no attempt to replicate.
Randomization Datasets were randomly assigned to the different sets (training, test and validation).
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The 170 images from the TCGA used as a test set were classified by 3 pathologists independently, and using only the visual information from each slide.
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